B
Bull
Bull · 25%RKDA
$5.40
Precio del escenario
$0.504
-0.015 (-2.97%)Al cierre
Loading chart…
- High
- 0.540
- Open
- 0.505
- VWAP
- 0.51
- Vol
- 68.69K
- Mkt Cap
- 4.25M
- Low
- 0.490
- Amount
- 35.11K
- EV/EBITDA, TTM
- 1.10
Arcadia Biosciences, Inc. is a producer and marketer of plant-based health and wellness products. The Company’s product portfolio includes Zola Coconut Water (Zola) and Agronomic Wheat Traits. Zola is a natural, 100% coconut water. Zola is a non-genetically modified organisms (non-GMO) project verified and only contains 60 calories per serving. Zola flavors include original, original with pulp, espresso, lime and pineapple. The recipe with Zola includes smoothies, desserts, cocktails and mocktails, and bowls. It has developed a portfolio of non-GMO specialty wheat traits to offer healthier, nutrient-rich wheat options while providing the same baking quality, taste, and texture as traditional wheat. Its non-GMO Reduced Gluten High Fiber Wheat has fewer allergenic glutens and higher fiber than traditional wheat, while its non-GMO Extended Shelf-Life Wheat extends the shelf life of milled whole wheat flour.
AI analysis of Arcadia Biosciences Inc (RKDA)
holdArcadia Biosciences Inc (RKDA) is currently not a strong buy. The stock is trading at $0.53, down 75.35% year-to-date, and has a forward P/E ratio of 36.63, indicating that while it may be undervalued, significant risks remain.
Analyst Ratings (1)
Hold
0 Buy
1 Hold
0 Sell
Current: 0.50
Mínimo
—
Promedio
—
Máximo
—
HC Wainwright & Co.
Strong Buy
$6
2024-08-21
HC Wainwright & Co.
2024-08-21
Precio objetivo
$6
Strong Buy
HC Wainwright & Co.
Strong Buy
$6
2024-05-23
HC Wainwright & Co.
2024-05-23
Precio objetivo
$6
Strong Buy
HC Wainwright & Co.
Strong Buy
$10
2024-04-05
HC Wainwright & Co.
2024-04-05
Precio objetivo
$10
Strong Buy
HC Wainwright & Co.
Strong Buy
$10
2023-08-28
HC Wainwright & Co.
2023-08-28
Precio objetivo
$10
Strong Buy
HC Wainwright & Co.
Strong Buy
$15
2023-07-24
HC Wainwright & Co.
2023-07-24
Precio objetivo
$15
Strong Buy
Métricas de valoración
The current forward P/E ratio for Arcadia Biosciences Inc (RKDA) is 36.63, compared to its 5-year average forward P/E of 4.02.
Alphio AI Price Scenarios for RKDA
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Cronología de eventos
Noticias
8.506-13NewsfilterArcadia Biosciences Closes Private Placement Raising $4 Million
8.506-12seekingalphaArcadia Biosciences Announces Private Placement of Common Stock
8.506-12NASDAQ.COMArcadia Biosciences Announces Stock Offering
- 8.506-12Newsfilter
Arcadia Biosciences Announces Private Placement of Common Stock
- 9.503-26seekingalpha
Arcadia Biosciences Reports Q4 Financial Results
RKDA FAQ — answered by Alphio AI
Arcadia Biosciences, Inc. is a producer and marketer of plant-based health and wellness products. The Company’s product portfolio includes Zola Coconut Water (Zola) and Agronomic Wheat Traits. Zola is a natural, 100% coconut water. Zola is a non-genetically modified organisms (non-GMO) project verified and only contains 60 calories per serving. Zola flavors include original, original with pulp, espresso, lime and pineapple. The recipe with Zola includes smoothies, desserts, cocktails and mocktails, and bowls. It has developed a portfolio of non-GMO specialty wheat traits to offer healthier, nutrient-rich wheat options while providing the same baking quality, taste, and texture as traditional wheat. Its non-GMO Reduced Gluten High Fiber Wheat has fewer allergenic glutens and higher fiber than traditional wheat, while its non-GMO Extended Shelf-Life Wheat extends the shelf life of milled whole wheat flour. It operates in the Consumer Non-Cyclicals sector.
Arcadia Biosciences Inc (RKDA) is currently not a strong buy. The stock is trading at $0.53, down 75.35% year-to-date, and has a forward P/E ratio of 36.63, indicating that while it may be undervalued, significant risks remain.
1 analysts cover RKDA: 0 rate it Buy, 1 Hold and 0 Sell.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.